08 Oct Abbott’s ID NOW Can Confirm Flu Infection in 13 Minutes or Less
MedicalResearch.com Interview with:
Dr. Norman Moore PhD
Abbott’s Director of Scientific Affairs for Infectious Diseases
MedicalResearch.com: What is the background for this test? How does ID NOW differ from other tests for influenza?
Response: This test was developed to give providers – and their patients – lab-accurate results more quickly than ever, right at the point of care. It was designed for ease of use, as well as to be portable and small enough that it can be used in a broad range of healthcare settings, including walk-in clinics, urgent care centers, doctors’ offices and emergency rooms.
Prior to ID NOW, traditional molecular tests offered great performance, but took too long to impact treatment decisions. ID NOW is able to deliver the performance and accuracy of lab-based tests in a timeframe that offers the best chance of improving treatment decisions.
MedicalResearch.com: How quickly can a diagnosis of flu be made or excluded with ID NOW? Will the test be widely available? Affordable?
Response: Abbott’s molecular point-of-care flu test, ID NOW, provides polymerase chain reaction (PCR) caliber results in 13 minutes or less. It was also the first to bring the enhanced sensitivity of molecular diagnosis to the point-of-care setting. With quicker, more accurate molecular flu testing, patients can begin treatment and recovery sooner.
ID NOW will be widely available this fall and can be found in a broad range of healthcare settings, including walk-in clinics, urgent care centers, doctors’ offices, emergency rooms and laboratories.
When it comes to affordability, one of the great benefits ID NOW offers is that it may help limit unnecessary testing. If someone is diagnosed with influenza, the doctor is able to rule out any concerns for other illnesses, such as pneumonia, without the need for additional tests, such as chest x-rays and culture.
MedicalResearch.com: Is there anything else you would like to add?
Response: Yes, I’d like to emphasize that getting a fast and accurate flu diagnosis leads to better health outcomes. Abbott’s point-of-care flu test portfolio helps providers make more confident and informed treatment decisions in an actionable timeframe, getting people on the path to feeling better sooner.
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on October 8, 2018 by Marie Benz MD FAAD